EMROK
Across
- 2. Quinolone-resistant coagulase-negative staphylococci
- 6. Effective against a wide range of bacterial pathogens
- 7. Cell wall-deficient atypical respiratory pathogen
- 8. Common setting for multidrug-resistant infections
- 10. Responsive to antimicrobial treatment
- 11. Gram-positive cocci responsible for pharyngitis, skin infections and invasive disease
- 15. Treatment started before culture results are available
- 16. Quinolone-resistant Staphylococcus aureus
- 18. Bacteria that grow in the absence of oxygen
- 20. Methicillin-resistant coagulase-negative staphylococci
- 21. Common lower respiratory tract infection
Down
- 1. Cause of Legionnaires' disease
- 3. Ability of bacteria to survive antibiotic therapy
- 4. Intracellular atypical bacterial pathogen
- 5. Methicillin-resistant Staphylococcus aureus
- 6. Kills bacteria rather than merely inhibiting growth
- 9. Opportunistic Gram-negative pathogen associated with hospital infections
- 12. Gram-positive cocci commonly causing UTIs and endocarditis
- 13. Vancomycin-intermediate Staphylococcus aureus
- 14. Protective community of bacteria attached to a surface
- 17. Vancomycin-resistant Staphylococcus aureus
- 19. Featured antibiotic brand